On Monday, Following Stocks were among the “Top 100 Losers” In U.S. Stock Exchange: Capstone Turbine (NASDAQ:CPST), Noble Energy, (NYSE:NBL), Northern Oil & Gas, (NYSEMKT:NOG), Alkermes (NASDAQ:ALKS)
On March 23, 2015 Capstone Turbine Corporation (NASDAQ:CPST) the world’s leading clean technology manufacturer of microturbine energy systems, uncovered that it has secured an order to upgrade the Salvaplastic manufacturing plant in San Salvador, El Salvador.
This will serve as Capstone’s first project in El Salvador with hopes that it will encourage the development of future projects there. El Salvador is experiencing noteworthygrowth in its manufacturing sector despite a decline in the number of manufacturing plants that import and assemble components for export, also known as maquiladoras.
Capstone Turbine Corporation (NASDAQ:CPST)’s shares picked down -3.32%, and closed at $0.640. The stock volatility for the week is 5.54%, while for the month remained 4.69%. The company holds consensus target price of $1.43.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.06 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 28.60% and Annual EPS growth for the past 5 years is considered as 27.50%.
The mean recommendation of analysts for this stock is 2.00. (Where 1=Buy, 5=Sale).
Capstone Turbine Corporation (CPST) develops, manufactures, markets, and services microturbine technology solutions for use in stationary distributed power generation applications worldwide. The corporation offers microturbine units, subassemblies, components, and various accessories for applications, counting cogeneration comprising combined heat and power (CHP) and integrated CHP, in addition to combined cooling, heat, and power; and renewable energy, natural resources, and critical power supply.
Noble Energy, Inc. (NYSE:NBL) declined -3.01%, and closed at $46.40. The company has the market capitalization of $18.65 billion. The beta value of the stock is 1.33. On the other hand the stock’s volatility for the week is 3.95%, and for the month is 2.87%. The stock’s price to book ratio is $1.62, however price to sale ratio is $3.55. Analyst’s mean recommendation regarding this stock is 2.40. (Where 1=Buy, 5=Sale).
Noble Energy, Inc. (NBL) an independent energy corporation holds in the attainment, exploration, and production of crude oil, natural gas, and natural gas liquids worldwide. Its principal projects are located in onshore DJ Basin and Marcellus Shale, the United States; the deepwater Gulf of Mexico; offshore West Africa; and offshore Eastern Mediterranean.
Formerly On February 26, 2015 Northern Oil & Gas, Inc. (NYSEMKT:NOG) proclaimed 2014 fourth quarter and full year results, year-end proved reserves, and 2015 production and capital budget guidance.
Annual production raised 29% to 5.8 million barrels of oil equivalent (“Boe”), or 15,794 average Boe per day
Fourth quarter production raised 29% year-over-year to 17,985 average Boe per day
2014 oil and gas sales raised 17% to $431.6 million
Proved reserves raised 20% to 100.7 million Boe and pre-tax PV-10 reached $1.7 billion
Added 589 gross (41.6 net) producing wells, bringing total producing wells to 2,338 gross (185.7 net)
Northern Oil & Gas, Inc. (NYSEMKT:NOG) decreased -2.98%, and closed at $6.84. The company holds the market capitalization of $430.51 million. For the last twelve months, the stock was able to keep return on equity at 24.60%, while return on assets at 9.20%, in response to its return on investment at 13.00%. Its 20-day moving average decreased -9.64%, below 50-day moving average of -6.48%, below 200-day moving average of -41.03% from the latest market price of $6.84. The mean recommendation of analysts for this stock is 2.80. (Where 1=Buy, 5=Sale).
Northern Oil & Gas, Inc. (NOG) an independent energy corporation involves in the attainment, exploration, development, and production of oil and natural gas properties in the United States.
23 hours ago Alkermes Plc (NASDAQ:ALKS) promulgated that medical data on aripiprazole lauroxil, an investigational, novel, long-acting injectable atypical antipsychotic for the treatment of schizophrenia, and ALKS 3831, an investigational, novel, oral atypical antipsychotic drug candidate designed to be a broad-spectrum treatment for schizophrenia, are planned to be presented at the 15th International Congress on Schizophrenia Research (ICOSR) in Colorado Springs, Colo., March 28-April 1, 2015.
Alkermes Plc (NASDAQ:ALKS) fell -2.95%, and closed at $65.22. The stock has the beta value of 1.05, and its volatility for the week is 3.38%, while for the month it is 3.53%. The company has the market capitalization of $9.95 million. The company holds the book value per share of 9.51, whereas cash per share is 4.26. Price to book ratio remained 6.86, while price to sale ratio is 15.61. Analysts mean recommendation for the stock is said to be 2.30 (where 1=Buy, 5=sale).
Alkermes Plc (ALKS) an integrated biopharmaceutical corporation, holds in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
